BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Thongprayoon C, Vaitla P, Craici IM, Leeaphorn N, Hansrivijit P, Salim SA, Bathini T, Rivera FHC, Cheungpasitporn W. The Use of Donor-Derived Cell-Free DNA for Assessment of Allograft Rejection and Injury Status. J Clin Med 2020;9:E1480. [PMID: 32423115 DOI: 10.3390/jcm9051480] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 5.5] [Reference Citation Analysis]
Number Citing Articles
1 Qazi Y, Patel A, Fajardo M, McCormick S, Fehringer G, Ahmed E, Malhotra M, Demko ZP, Billings PR, Tabriziani H, Gauthier P. Incorporation of Donor-derived Cell-free DNA Into Clinical Practice for Renal Allograft Management. Transplant Proc 2021:S0041-1345(21)00710-7. [PMID: 34774309 DOI: 10.1016/j.transproceed.2021.09.027] [Reference Citation Analysis]
2 Westphal SG, Mannon RB. Emerging biomarkers in kidney transplantation and challenge of clinical implementation. Curr Opin Organ Transplant 2022;27:15-21. [PMID: 34939960 DOI: 10.1097/MOT.0000000000000941] [Reference Citation Analysis]
3 Martuszewski A, Paluszkiewicz P, Król M, Banasik M, Kepinska M. Donor-Derived Cell-Free DNA in Kidney Transplantation as a Potential Rejection Biomarker: A Systematic Literature Review. J Clin Med 2021;10:E193. [PMID: 33430458 DOI: 10.3390/jcm10020193] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Jackson AM, Amato-Menker C, Bettinotti M. Cell-free DNA diagnostics in transplantation utilizing next generation sequencing. Hum Immunol 2021;82:850-8. [PMID: 34600770 DOI: 10.1016/j.humimm.2021.07.006] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Kumar N, Rana R, Rana DS, Gupta A, Sachdeva MP. Donor-Derived Cell-Free DNA to Diagnose Graft Rejection Post-Transplant: Past, Present and Future. Transplantology 2021;2:348-61. [DOI: 10.3390/transplantology2030034] [Reference Citation Analysis]
6 Afzal A, Alam A, van Zyl JS, Zafar H, Felius J, Hall SA, Carey SA. Observed elevated donor-derived cell free DNA in orthotopic heart transplant recipients without clinical evidence of rejection. Clin Transplant 2021;:e14549. [PMID: 34863042 DOI: 10.1111/ctr.14549] [Reference Citation Analysis]
7 Capuzzimati M, Hough O, Liu M. Cell Death and Ischemia-Reperfusion Injury in Lung Transplantation. The Journal of Heart and Lung Transplantation 2022. [DOI: 10.1016/j.healun.2022.05.013] [Reference Citation Analysis]
8 Lum EL, Lee S, Zuckerman J, Bunnapradist S. Subclinical non-HLA AMR detection and monitoring with surveillance dd-cfDNA in a kidney transplant recipient. Transplantation Reports 2022;7:100092. [DOI: 10.1016/j.tpr.2022.100092] [Reference Citation Analysis]
9 Halloran PF, Reeve J, Madill-thomsen KS, Demko Z, Prewett A, Billings P; the Trifecta Investigators*. The Trifecta Study: Comparing Plasma Levels of Donor-derived Cell-Free DNA with the Molecular Phenotype of Kidney Transplant Biopsies. JASN. [DOI: 10.1681/asn.2021091191] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 9.0] [Reference Citation Analysis]
10 Kataria A, Kumar D, Gupta G. Donor-derived Cell-free DNA in Solid-organ Transplant Diagnostics: Indications, Limitations, and Future Directions. Transplantation 2021;105:1203-11. [PMID: 33534526 DOI: 10.1097/TP.0000000000003651] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
11 Seeto RK, Fleming JN, Dholakia S, Dale BL. Understanding and using AlloSure donor derived cell-free DNA. Biophys Rev 2020;12:917-24. [PMID: 32683591 DOI: 10.1007/s12551-020-00713-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
12 Quaglia M, Merlotti G, Guglielmetti G, Castellano G, Cantaluppi V. Recent Advances on Biomarkers of Early and Late Kidney Graft Dysfunction. Int J Mol Sci 2020;21:E5404. [PMID: 32751357 DOI: 10.3390/ijms21155404] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
13 Lum EL, Nieves-borrero K, Homkrailas P, Lee S, Danovitch G, Bunnapradist S. Title: Single center experience comparing two clinically available donor derived cell free DNA tests and review of literature. Transplantation Reports 2021;6:100079. [DOI: 10.1016/j.tpr.2021.100079] [Reference Citation Analysis]
14 Wolf-Doty TK, Mannon RB, Poggio ED, Hinojosa RJ, Hiller D, Bromberg JS, Brennan DC. Dynamic Response of Donor-Derived Cell-Free DNA Following Treatment of Acute Rejection in Kidney Allografts. Kidney360 2021;2:729-36. [PMID: 35373051 DOI: 10.34067/KID.0000042021] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
15 Williams MD, Thomas J, Paner A, Chan EY, Hollinger EF, Schadde E, Hertl M, Santos CAQ, Olaitan OK. Can Donor-Derived Cell-Free DNA Detect Graft-Versus-Host Disease in Solid Organ Transplantation: A Case Report. Transplant Proc 2021:S0041-1345(21)00884-8. [PMID: 34961600 DOI: 10.1016/j.transproceed.2021.11.014] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Pilch NA, Bowman LJ, Taber DJ. Immunosuppression trends in solid organ transplantation: The future of individualization, monitoring, and management. Pharmacotherapy 2021;41:119-31. [PMID: 33131123 DOI: 10.1002/phar.2481] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
17 Melancon JK, Khalil A, Lerman MJ. Donor-Derived Cell Free DNA: Is It All the Same? Kidney360 2020;1:1116-21. [DOI: 10.34067/kid.0003512020] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 3.5] [Reference Citation Analysis]